Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    "Catastrophic antiphospholipid syndrome"
Show Display Options
Rank Status Study
1 Active, not recruiting Eculizumab to Enable Renal Transplantation in Patients With History of Catastrophic Antiphospholipid Antibody Syndrome
Conditions: Antiphospholipid Antibody Syndrome;   End Stage Renal Disease
Intervention: Drug: Eculizumab

Indicates status has not been verified in more than two years